Published Letters

29th Jan 2018

GPs to stop prescribing strong painkillers: Major issues ignored

Source: The Age
By: Dr Tim Woodruff

The Therapeutic Goods Administration discussion paper suggesting general practitioners should no longer be able to prescribe strong painkillers (“GPs face ban on painkillers”, The Age, 27/1) ignores two major issues.

Firstly, many GPs are competent and capable of playing their part in managing patients with chronic pain, including palliative care, but they often have little access to the supports needed to manage complex issues such as poverty, illicit drug abuse, mental health, and addiction, or knowledge of how often the patient is getting second supplies of the drugs through another doctor.

Secondly, the suggestion that pain specialists will be able to replace GPs is laughable. Many patients with chronic pain are poor because they can’t work. Private pain specialists are often very expensive. Two of my patients were told by their specialists last year that as WorkCover had ceased they would have to pay a huge co-payment despite being on Newstart and drastically below the poverty line. These specialists were managing their income not their patients’ health.

Public pain clinics exist but are limited, with waiting times of months to years. The federal government continues to underfund the public system in its pursuit of privatisation of our health system with public care as a miserable safety net.

What will patients do? Suffer more.

1st May 2017

Narrow Vision of Elites

The Age
By: Dr Tim Woodruff

The most important part of a nation’s infrastructure is the people. People who are sick are less productive. Parents, children and partners of sick people are less productive as they take time to care for loved ones.
But this government has systematically attacked investment in the health of that infrastructure (the people) by freezing the Medicare rebate, and cutting promised dental care and funding to multiple community-based care organisations and so on. The aim of making Australia more productive reflects the narrow vision of the elites who run our country. Instead the government will continue to subsidise the private health and hospitals industries and pay $445 million above world market prices to the pharmaceutical industry for prescription drugs.

18th Apr 2017

Medicare safety net a Coalition gimmick

The Age
By: Dr Tim Woodruff

The abuse of the extended Medicare safety net is no surprise (The Age, 15/4). When it was introduced by John Howard, the Victorian branch of the Australian Medical Association detailed in its monthly newsletter how a psychiatrist could make more money without any extra care or cost to the patient. Also, most of the money spent through the safety net goes to rich electorates. Very little goes to patients in poor electorates. The scheme has helped many doctors financially but was a gimmick designed to fool people into believing the Coalition cared about out-of-pocket costs. In fact, the Medicare rebate freeze sends a clear message this government wants patients to pay more out of their pocket.

Dr Tim Woodruff, Doctors Reform Society

26th Apr 2016

Vanstone Ley Selective Efficiency

By: Dr Tim Woodruff

Published in the age on Tuesday, April 26, 2016

Amanda Vanstone claims the Health Minister understands efficiency  (Comment, 25/4). However, Sussan Ley’s view of efficiency is selective. Documented savings of $1 billion per year would be made if the government paid world market prices for pharmaceuticals. But it refuses to tackle the issue and continues to receive donations from the pharmaceutical industry. Also, some $8 billion is spent on the inefficient private health insurance rebate.

Read more

26th Apr 2016

Selective efficiency

By: Dr Tim Woodruff

Published in Australian on Tuesday, April 26, 2016

The claim that there are huge unnecessary costs in the health system is one we have been pointing out for years. It is encouraging that the Federal Government is showing some limited interest in this issue. The approach however, is half hearted. It continues to ignore the $1 billion savings which could be achieved if our Pharmaceutical Benefits Scheme paid world market prices for drugs. Thus for the the breast cancer treatment Arimidex, the taxpayer  pays 30 times more than in Britain, and for cholesterol lower drugs it costs 10 times as much in Australia than in both Britian and New Zealand. But pharmaceutical companies are good political donors.

Read more

27th Feb 2016

Health minister’s prostheses cost inquiry welcomed but……..

By: Dr Tim Woodruff

Published in smh on Saturday, February 27, 2016

It’s great to see the Minister for Health, Sussan Ley, asking why prostheses such as hip replacements and pacemakers cost so much more than world market prices in the private system (“Prosthetic procedure cost disparity targeted“, February 26).

Read more

11th Feb 2016

Medicare sell off: where’s the care factor?

By: Dr Tim Woodruff

Published in Age on Thursday, February 11, 2016

Reports that the Medicare and related billing systems may be privatised should send a shudder through the hearts of all Australians who struggle daily with the changes due to the otherwise amazing technology (“PM rolls dice on Medicare”, 10/2). Read more

1st Dec 2015

Money, the bottom line

By: Dr Tim Woodruff

Published in the Age on Tuesday, December 1, 2015

Money, the bottom line

The federal government’s changes to how mental health care is delivered are indeed welcome although somewhat belated (Editorial, 30/11). But there is no new funding to enable the changes to be implemented.

Read more